IL-10 knockdown with siRNA enhances the efficacy of Doxorubicin chemotherapy in EBV-positive tumors by inducing lytic cycle via PI3K/p38 MAPK/NF-kB pathway | |
Gao Li; Han Haige; Wang Honglei; Cao Li; Feng Wen-Hai | |
2019 | |
卷号 | 462页码:12-22 |
关键词 | EBV reactivation EBV-Associated tumors IL-10 silencing VEGF |
ISSN号 | 1872-7980 |
DOI | 10.1016/j.canlet.2019.07.016 |
URL标识 | 查看原文 |
收录类别 | PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6339049 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Gao Li,Han Haige,Wang Honglei,et al. IL-10 knockdown with siRNA enhances the efficacy of Doxorubicin chemotherapy in EBV-positive tumors by inducing lytic cycle via PI3K/p38 MAPK/NF-kB pathway[J],2019,462:12-22. |
APA | Gao Li,Han Haige,Wang Honglei,Cao Li,&Feng Wen-Hai.(2019).IL-10 knockdown with siRNA enhances the efficacy of Doxorubicin chemotherapy in EBV-positive tumors by inducing lytic cycle via PI3K/p38 MAPK/NF-kB pathway.,462,12-22. |
MLA | Gao Li,et al."IL-10 knockdown with siRNA enhances the efficacy of Doxorubicin chemotherapy in EBV-positive tumors by inducing lytic cycle via PI3K/p38 MAPK/NF-kB pathway".462(2019):12-22. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论